We are live on
!
Find out more
MMPI
Morgenthaler Management Partners IX Portfolio holdings
AUM
$22.6M
This Fund
S&P 500
This Quarter
Est. Return
+17.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.6M
AUM Growth
-$24.3M
(-52%)
Cap. Flow
-$27.5M
Cap. Flow
% of AUM
-121.88%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$27.5M |
Sector Composition
| 1 | Healthcare | 100% |
Similar funds
DPA
HCA
TCM
AC
MP
WAM
AF
KAM
Morgenthaler Management Partners IX's Q2 2019 Portfolio in Review
As of Q2 2019, Morgenthaler Management Partners IX held 2 positions worth $22.6M, down 52% from $46.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Morgenthaler Management Partners IX withdrew a net $27.5M in Q2 2019, closing 1 position. Its most notable exit was Ra Pharmaceuticals, Inc. Common Stock, an estimated $27.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Morgenthaler Management Partners IX fully exited Ra Pharmaceuticals, Inc. Common Stock in Q2 2019, selling an estimated $27.5M.
- Morgenthaler Management Partners IX's ten largest holdings make up 100% of its $22.6M portfolio in Q2 2019.
- Morgenthaler Management Partners IX opened 0 new positions and closed 1 in Q2 2019.
- Morgenthaler Management Partners IX's portfolio value fell 52% quarter-over-quarter to $22.6M.
Based on Morgenthaler Management Partners IX's 13F filing for Q2 2019, filed 14 Aug 2019.